丹红注射液治疗在冠心病的临床疗效
The Clinical Effect of CDSP Treatment for Coronary Heart Disease
-
摘要: ［摘要］目的 探讨丹红注射液在冠心病的治疗中的效果．方法 选取100例冠心病患者，按照单纯随机抽样分组方法，将其分为实验组和对照组各50例，对照组患者给予β受体阻滞剂、硝酸甘油、阿司匹林等常规治疗．实验组在给予以上常规治疗的基础上，加用静脉滴注丹红注射液20～30 mL/次，1次/d．2组均以1个月为1个疗程．记录2组患者治疗前后TC、HDL-C、LDL-C、CRP、D-二聚体变化情况、心绞痛变化．结果 与对照组相比，实验组治疗后心电图和心绞痛临床疗效更显著，差异具有统计学意义（P＜0.05）；实验组与对照组患者在治疗前TC、HDL-C、LDL-C、CRP、D-二聚体无统计学差异（P＞0.05），而治疗后实验组TC、HDL-C、LDL-C、CRP、D-二聚体较对照组有明显差异，差异具有统计学意义（P＜0.05）．结论 丹红注射液可以有效改善冠心病的相关指标及症状．Abstract: ［Abstract］Objective To analyze the clinical effect of between CDSP and CDSP combined with cardiovascular drugs treatment for coronary heart disease. Methods We selected 100 patients with coronary heart disease，and used the random grouping method to divide them into experimental group（n＝50） and control group（n＝50）. Experimental group was given CDSP combined with cardiovascular routine treatment for 1month， the control group was given cardiovascular routine therapy for 1 month. We compared the clinical effect and the serum level of TC，HDL-C，LDL-C，CRP and D-dimer between experimental group and control group．Results After treatment， the clinical effects on angina（P＜0.05） and electrocardiogram（ P＜0.05）of experimental group were better than control group. Before treatment， there was no significant difference between experimental group and control group in the serum levels of TC，HDL-C，LDL-C，CRP and D-dimer （P＞0.05）. After treatment， the serum levels of TC，HDL-C，LDL-C，CRP and D-dimer of experimental group is significant better than control group（P＞0.05）. Conclusions CDSP can effectively relieve the main symptoms of coronary heart disease.
-
点击查看大图
计量
- 文章访问数: 3521
- HTML全文浏览量: 1304
- PDF下载量: 185
- 被引次数: 0
下载:
